Skip to main content
. 2002 Feb;53(2):173–181. doi: 10.1046/j.0306-5251.2001.01220.x

Table 2.

Observed (Obs) and expected (Exp) number and O/E ratios of UGIB associated with current and former NSAID use among persons with at least one NSAID prescription recorded in the North Jutland County Pharmaco-Epidemiologic Prescription Database, 1991–95. Exposure window is 90 days for all drugs considered.

Periods of drug use Number of persons Person-years Obs UGIB Exp O/E 95% CI
Current use of NSAID 156 138 107 305 515 124.9 4.12 3.8, 4.5
 NSAID only 152 882 94 987 365 101.2 3.61 3.3, 4.0
 NSAID+glucocorticoids 17 875 5908 58 8.0 7.24 5.5, 9.4
 NSAID+glucocorticoids+other drug (not anticoagulants) 1593 464 7 1.1 6.41 2.6, 13.2
 NSAID+anticoagulants 1001 340 8 0.7 11.46 4.9, 22.6
 NSAID+anticoagulants+other drug (not glucocorticoids) 178 35 0 0.1
 NSAID+glucocorticoids+anticoagulants±other drugs 154 29 1 0.1 18.74 0.2, 10.4
 NSAID±lowdose aspirin±highdose aspirin 10 246 5542 76 13.8 5.52 4.3, 6.9
Former use of NSAID 145 8771 314 278 370 264.4 1.40 1.3, 1.5
 Non use of any other drug2 144 584 294 676 267 224.9 1.19 1.0, 1.3
 Current use of other drug2 (not NSAID) 28 455 19 602 103 39.6 2.60 2.1, 3.2
1

Among the 156 138 NSAID users, 145 877 were followed during periods of non use 90 or more days after a nonrenewed prescription.

2

The category includes drugs suspected to predispose to UGIB (low-and high dose aspirin, anticoagulants and glucocorticoids).